Antiplatelet and Anticoagulant Therapy in the 2025 ACC/AHA Guideline for Acute Coronary Syndromes DOI
Behnood Bikdeli, Francisco Ujueta, Sina Rashedi

и другие.

Journal of the American College of Cardiology, Год журнала: 2025, Номер 85(22), С. 2074 - 2078

Опубликована: Июнь 1, 2025

Язык: Английский

Bursting the Balloon DOI
Clément Delmas,

Miloud Cherbi,

François Roubille

и другие.

Journal of the American College of Cardiology, Год журнала: 2025, Номер unknown

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

1
Post Procedural Anticoagulation After Percutaneous Coronary Intervention in Patients With St-segment Elevation Myocardial Infarction : a Systematic Review and Meta-analysis DOI
R Motta,

E. Silva,

Tarek Castro Fayyat

и другие.

Research Square (Research Square), Год журнала: 2025, Номер unknown

Опубликована: Май 15, 2025

Abstract Purpose: This meta-analysis aims to evaluate the post-procedural anticoagulation in patients with ST-segment elevation after percutaneous coronary intervention Methods: A systematic review and search was conducted PubMed, Scoups, Embase, Cochrane databases identify relevant trials cohort studies adhering following PRISMA established guidelines. The inclusion criteria covered that use of PPA STEMI PCI, exclusion used before periprocedural underwent artery bypass grafting. main outcomes analyzed were all-cause mortality, cardiac death, reinfarction, stent thrombosis stroke, comparing group control group. Statistical analysis performed using R software (version 4.2.3, Foundation for Computing, Vienna, Austria) under random-effects model estimate pooled assess heterogeneity. Results: Across included studies, no statistically significant differences observed between postprocedural (AC) (NAC) any evaluated outcomes. For mortality (9 studies; 39,915 AC vs. 24,208 NAC), risk ratio (RR) 0.76 [95% CI: 0.54–1.07; p = 0.1168; I² 77.1%]. Cardiac death (6 32,523 17,190 NAC) showed an RR 0.72 0.49–1.05; 0.0906; 77.7%]. Reinfarction (8 39,747 23,950 had 0.79 0.48–1.31; 0.3657; 82.3%]. 23,946 1.17 0.91–1.49; 0.2160; 18.0%]. Stroke 39,839 24,116 1.07 0.75–1.51; 0.7170; 29.1%], bleeding 32,741 17,475 0.96 0.60–1.53; 0.8603; 89.5%]. Finally, major adverse cardiovascular events (MACE) 17,186 0.71 0.43–1.18; 0.1899; 92.6%]. Conclusion: shows routine primary PCI does not significantly reduce events, likely due effective antiplatelet therapy procedural advances. findings align current guidelines discouraging its use. personalized approach remains essential balance ischemic risks.

Язык: Английский

Процитировано

0
Eternal Battle in Multivessel Disease DOI
Simone Fezzi, Bruno Scheller

КАРДИОЛОГИЯ УЗБЕКИСТАНА, Год журнала: 2025, Номер 18(7), С. 849 - 852

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0
Complete Revascularization (CR) Versus Culprit‐Only Percutaneous Coronary Intervention (CO‐PCI) in NSTE‐ACS with Multivessel Disease: A Systematic Review and Meta‐Analysis DOI
Kesar Prajapati, Shanmukh Sai Pavan Lingamsetty, Harshith Thyagaturu

и другие.

Catheterization and Cardiovascular Interventions, Год журнала: 2025, Номер unknown

Опубликована: Апрель 28, 2025

ABSTRACT Objective Contemporary data have demonstrated that a complete revascularization (CR) strategy reduces adverse cardiovascular events compared with culprit vessel only‐Percutaneous Coronary Intervention (CO‐PCI) in ST Elevation Myocardial Infarction (STEMI). The optimal of CR versus CO‐PCI Non‐ST‐Elevation Acute Syndrome (NSTE‐ACS) remains unclear and was the goal this meta‐analysis. Methods A systematic search PubMed, Embase, Cochrane databases for English‐language studies from inception till November 2024 comparing NSTE‐ACS patients multi‐vessel disease performed. meta‐analysis performed using random‐effects model to calculate risk ratio (RR) 95% confidence interval (CI). Primary outcomes were all‐cause mortality myocardial reinfarction. Results Eleven total 36,997 included study mean follow up 31.3 months. showed reduction (1,457 16,939) (2126 (RR: 0.66; CI: 0.55 0.79). reinfarction occurred 149 6404 248 group (RR:0.57; 0.43 0.76). Composite endpoint noted 299 2,129 vs 418 2131 CO‐ PCI (RR:0.72; 0.63 0.82). Repeat 504 5661 849 5663 (RR:0.60; 0.54 0.66). Conclusion In NSTEMI multivessel disease, mortality, recurrent infarction, composite outcome, repeat CO‐PCI.

Язык: Английский

Процитировано

0
Lesion Preparation Complete – You May Now Deploy Your Stent DOI Creative Commons
Eric S. Rothstein,

Nathan L Crain,

Jarrod Frizzell

и другие.

Journal of the Society for Cardiovascular Angiography & Interventions, Год журнала: 2025, Номер 4(5), С. 103604 - 103604

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women DOI Creative Commons
Suzanne J. Baron, Josephine Chou, Tayyab Shah

и другие.

Journal of the Society for Cardiovascular Angiography & Interventions, Год журнала: 2025, Номер unknown, С. 102150 - 102150

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0
Factors Contributing to Low Utilization of Intracoronary Imaging in Clinical Practice: A White Paper DOI Creative Commons
Javier Escaned, Marco Lombardi, Matthias Götberg

и другие.

Journal of the Society for Cardiovascular Angiography & Interventions, Год журнала: 2025, Номер unknown, С. 103607 - 103607

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0
Making Progress Toward Complete Revascularization of Multivessel Disease After STEMI DOI
Francis R. Joshi

КАРДИОЛОГИЯ УЗБЕКИСТАНА, Год журнала: 2025, Номер 18(10), С. 1260 - 1262

Опубликована: Май 1, 2025

Язык: Английский

Процитировано

0
ACS Guidelines DOI
J J Coughlan,

Rasha Al Lamee,

Robert A. Byrne

и другие.

Journal of the American College of Cardiology, Год журнала: 2025, Номер 85(22), С. 2118 - 2121

Опубликована: Июнь 1, 2025

Язык: Английский

Процитировано

0
Mechanical Circulatory Support in Acute Myocardial Infarction–Cardiogenic Shock DOI
Karthik Murugiah,

Theresa A. McDonagh,

David J. Cohen

и другие.

Journal of the American College of Cardiology, Год журнала: 2025, Номер 85(22), С. 2103 - 2106

Опубликована: Июнь 1, 2025

Язык: Английский

Процитировано

0